Recognizing the risk of Propofol-related infusion syndrome (PRIS) with propofol, we are looking to learn what safety measures health systems have implemented around the use of propofol. I would appreciate your responses to the following questions and any additional feedback:

1) Do you limit duration of propofol infusions to 48 hours? If so, how is this accomplished?
2) What is your maximum allowed infusion rate for propofol?
3) Do you require use of adjusted body weight for dosing in obesity?
4) Do you require routine lab monitoring with propofol? If so, who is responsible and which labs (e.g. Trig, LFT, CK, ABG etc.)
5) Any other measures?

Thank you,
Daniel